ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Skin Diseases
Immune System Diseases
Eczematous Skin Diseases
Pruritus
Food Hypersensitivity

Eczema trials near San Antonio, TX, USA:

Locations recently updated

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...

Enrolling
Eczema
Drug: Abrocitinib
Other: Placebo

Phase 3

Pfizer
Pfizer

San Antonio, Texas, United States of America and 46 other locations

Locations recently updated

This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in childr...

Enrolling
Atopic Dermatitis
Drug: Abrocitinib

Phase 3

Pfizer
Pfizer

San Antonio, Texas, United States of America and 38 other locations

Locations recently updated

participants (in Part A) and participants with atopic dermatitis (eczema) (in Part B). REGN20423 is a study medicine that is only used in cl...

Enrolling
Atopic Dermatitis
Healthy Volunteer
Other: Placebo
Drug: REGN20423

Phase 1

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

San Antonio, Texas, United States of America and 4 other locations

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Enrolling
Eczema Atopic Dermatitis
Eczema, Atopic
Drug: Camoteskimab
Drug: Placebo

Phase 2

Apollo Therapeutics

San Antonio, Texas, United States and 84 other locations

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.

Active, not recruiting
Atoptic Dermatitis
Drug: EVO756
Drug: Placebo control

Phase 2

Evommune

San Antonio, Texas, United States of America and 26 other locations

This is a first-in-human, Phase 1, double-blind, randomized, placebo-controlled, dose-escalation study evaluating ARQ-234. The study is designed to a...

Enrolling
Eczema
Atopic Dermatitis (AD)
Drug: Placebo
Biological: ARQ-234

Phase 1

Arcutis Biotherapeutics
Arcutis Biotherapeutics

San Antonio, Texas, United States and 4 other locations

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Active, not recruiting
Atopic Dermatitis
Drug: Placebo
Drug: ADX-914

Phase 2

Q32 Bio

San Antonio, Texas, United States of America and 27 other locations

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

Phase 4

Lilly
Lilly

San Antonio, Texas, United States and 71 other locations

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

San Antonio, Texas, United States of America and 89 other locations

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Active, not recruiting
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

Phase 2

Bluefin Biomedicine, Inc.

San Antonio, Texas, United States of America and 88 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems